Clinical Trials Browser

Sulfonylurea Compounds × Clear all

NCT05663515 2026-05-05

EXCEED

24,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

21,692 enrolled

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT02475499 2016-03-14

Incretin-based Drugs and Pancreatic Cancer

886,172 enrolled

Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms